At this low pps, it might make sense to sell my warrants
At this low pps, it might make sense to sell my warrants which are in the green.
My warrant exercise cost of $4.04 would equal a double from here at $2
I wouldn't get as many shares, but would have the share value reflected in my account.
And I wouldn't have to come up with cash to buy the warrants.
Does this sound reasonable????
TON Strategy Co. (TONX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Navigating the AI Maze: Flux's New Pathways Ever feel like these engineering platforms speak a language of their own? Flux's latest expansion finally offers a translator that matters. It's all about decoding whether your AI investment is delivering the goods. Engineering leaders now have more than just fluffy metrics; Flux breaks down real code-based evidence to show if...
Continue Reading
Straight outta Burlington, the M&T Bank Vermont City Marathon is giving its course a facelift and, get this, throwing a half marathon into the mix for 2027. It's about time they shook things up, considering how this race is supposed to be one of the most welcoming on the block. I mean, you're talking about a marathon that's practically been the crown jewel of Vermont's...
Continue Reading
Revolutionizing the E-Commerce Landscape Wake up and smell the innovation, folks! SureDone is rolling out Taska AI, a tool that's set to declutter the chaotic world of enterprise marketplace listings. It's no bed of roses for sellers out there, dealing with diverse channel demands and post-submission hiccups. Taska AI steps in as the seasoned handyman these sellers...
Continue Reading
Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...
Continue Reading
Navigating the healthcare maze isn't for the faint of heart, especially when it comes to making sure that dollars spent on food benefits actually translate to improved health. Enter Foodsmart, the foodcare powerhouse that just rolled out its Food-is-Medicine Benefits Management (FBM) program. Turning Meals into Measurable Metrics Health plans are under mounting pressure...
Continue Reading
Ever found a protein shake that tastes like a candy bar from the future? Well, Hi-Tech Pharmaceuticals is banking on their new Dubai Chocolate flavor to hit that sweet spot. This isn't your typical powdered shake game; Hi-Tech's been cranking the flavor dial ever since they introduced their Precision Protein® line back in 2016. They've carved out a niche with unique...
Continue Reading
Revolutionizing Film Financing The film industry has always been a tough nut to crack. Imagine trying to keep your creative baby yours without surrendering the crown jewels of intellectual property. Well, now, the cavalry with a fresh game plan has arrived, and both investors and filmmakers might be ready for another round. This isn't the typical PR fairytale; it's...
Continue Reading
Rethinking Beauty Industry's AI Obsession Here’s a breath of fresh air from the otherwise AI-obsessed beauty landscape: SACHEU, the brand that's been turning heads in cosmetics, decided to pair up with Limitless Labs. This partnership isn't about ceding control to machines but amplifying genuine human voices in their product development process. Yeah, it's a...
Continue Reading
Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...
Continue Reading
Something's Buzzing at the Big Board Walk over to Wall Street on September 23rd, and guess what you get? A lot more than just stock tickers blinking away. First Lady Melania Trump’s stealing the show at the New York Stock Exchange to kick off the inaugural IMPERIA Summit. She’s there to sound the opening bell and lead the charge in a summit that's focused on the...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of the Medical Devices Market The global medical devices market is on a promising trajectory, anticipated to exceed US$ 905.56 billion by the year 2033 from a valuation of US$ 517.86 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.4% throughout the forecast period. This remarkable growth is largely influenced by various factors such as...
Continue Reading
Agenus Inc. Faces Class Action Lawsuit: Key Details for Investors Investors in Agenus Inc. are currently facing critical news regarding a class action securities lawsuit. This legal action has been initiated by Levi & Korsinsky, LLP, a firm that specializes in representing investors in cases related to securities litigation. The company, identified by the stock ticker...
Continue Reading
G6 Networks Unleashes GSX Token for Blockchain Transformation G6 Networks has made a remarkable advancement in the blockchain sector with the launch of its GSX token. This initiative promises to pave the way for greater transparency and accessibility within the blockchain community. Offered at a competitive price of $0.85 per token, the three-tier structured launch is...
Continue Reading
ASC47 and Semaglutide: A Promising Combination for Weight Loss Ascletis Pharma Inc. has unveiled exciting findings regarding its weight loss medication, ASC47, particularly when paired with Semaglutide. Participants suffering from obesity showed significantly improved outcomes with this innovative combination therapy, demonstrating a greater reduction in body weight...
Continue Reading
Reviva Pharmaceuticals Secures Funding for Advancement Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), a dedicated late-stage pharmaceutical company, is making significant strides in the development of innovative therapies aimed at addressing critical needs in the realms of central nervous system (CNS), inflammatory, and cardiometabolic diseases. Recently, Reviva...
Continue Reading